The Supreme Court could rule as soon as today in the legal battle over abortion pills — and could effectively override the Food and Drug Administration's decision-making if it doesn't turn back a ruling limiting the use of the drug mifepristone.
Why it matters: Until last week, such a sweeping blow against the FDA's authority would have been unprecedented. Now it's a real possibility — one that could quickly threaten access to the pill used in more than half of U.S. abortions.
